In summary, the evidence analysed and reported in this review supports the idea that p300 may be a relevant actor in diabetes-induced vascular inflammation and oxidative stress, which promote endothelial senescence, driving atherosclerotic cardiovascular disease. Here, EP300 is linked to diabetes mellitus.